BIVDA Press Releases


Comments on Prime Minister's Trade Speech

London - Monday 3 February 2020

The British In Vitro Diagnostic Association comments on Primer Minister's trade speech

The British In Vitro Diagnostic Association (BIVDA) has commented on Boris Johnson’s keynote speech today, in which he set out the British mandate for the forthcoming trade talks with the European Union, and other potential trade deals worldwide. 

Chief Executive Doris-Ann Williams MBE said;

“BIVDA welcome’s the Prime Minister’s intentions to strike a comprehensive trade agreement with the EU, and the stated intent to open negotiations with other major world markets. 

We would urge the Government however to bear in mind the importance of maintaining smooth supply lines and regulatory equivalence for the diagnostics and wider health care sector. 

Patients rely on timely access to safe and effective diagnostics equipment, and a smooth border with the EU will be vital for this to continue.” 

BIVDA has written to all relevant ministers in the Johnson government emphasising these priorities, and is engaging at the highest level to ensure the voice of the diagnostics sector is heard in advance of any trade talks.



BIVDA represents the in vitro diagnostics (IVDs) industry in the UK. BIVDA member companies employ 8,000 people directly in the UK and provide the tests and equipment to the NHS to allow rapid diagnosis. IVDs also enable screening for disease, monitoring and managing treatment and are vital to ensure the safety of the blood supply for transfusion. Information from IVD tests accounts for about 70% of the information on a patient’s record. Increasingly diagnostics are available for use in a primary care setting and to enable people to manage their own diseases from home. This reduces the need for hospitalised care and will improve quality of life for much of the population. Follow us on Twitter - @BIVDA

Contact: Jon Harrison     
299 Oxford Street
W1C 2DZ 


BIVDA and Diabetes UK call for urgent action on blood glucose monitoring

BIVDA and Diabetes UK are calling for healthcare professionals (HCPs) to take urgent action and chec...

Read More >

BIVDA response to the Secretary of State for Health and Social Care's vision for prevention

Today the Secretary of State for Health and Social Care, Matt Hancock MP, has announced his vision f...

Read More >

BIVDA response to Parliament’s vote on the Brexit deal

Doris-Ann Williams, Chief Executive of BIVDA, comments on Parliament’s vote on the Brexit deal

Read More >

BIVDA Launches Vision for Increasing Access to Molecular Diagnostics

A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...

Read More >

BIVDA's response to the 2019 General Election result

Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE sa...

Read More >

PwC analysis highlights economic footprint of UK Life Sciences

The productivity of the UK’s Life Sciences sector is more than double the UK average, says a new re...

Read More >